SEC Form 4/A · accession 0001437749-26-024418
Capstone Holding Corp. · CAPS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Michael Toporek
Director
Period of report
Mar 30, 2026
Accepted (ET)
Jul 24, 2026 · 4:28 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0000887151
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2,F3 | Mar 30, 2026 | A | 356,250 | — | A | 391,678 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This Form 4/A is being filed solely to correct the nature of the shares and the vesting schedule reported as granted on April 1, 2026. This amendment reflects that the shares granted were shares of common stock, rather than restricted stock units, and corrects the vesting schedule of the shares granted.
- F2Including 356,250 shares of common stock granted to the Reporting Person on March 30, 2026 as restricted stock awards, for no consideration. The restricted stock awards will vest in full only upon the Reporting Person's death or disability, removal from the Board of Directors other than for Cause, or failure to be re-elected to the Board of Directors. If the Reporting Person voluntarily resigns from the Board of Directors before the applicable vesting event, the restricted stock awards will be forfeited.
- F3Excludes 121,774 shares controlled by the Reporting Person, through his control of BP Peptides, LLC.